TY - JOUR
T1 - Original research Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis
AU - Ammer-Herrmenau, Christoph
AU - Antweiler, Kai L.
AU - Asendorf, Thomas
AU - Beyer, Georg
AU - Buchholz, Soeren M.
AU - Cameron, Silke
AU - Capurso, Gabriele
AU - Damm, Marko
AU - Dang, Linh
AU - Frost, Fabian
AU - Gomes, Antonio
AU - Hamm, Jacob
AU - Henker, Robert
AU - Hoffmeister, Albrecht
AU - Meinhardt, Christian
AU - Nawacki, Lukasz
AU - Nunes, Vitor
AU - Panyko, Arpad
AU - Pardo, Cesareo
AU - Phillip, Veit
AU - Pukitis, Aldis
AU - Rasch, Sebastian
AU - Riekstina, Diana
AU - Rinja, Ecaterina
AU - Ruiz-Rebollo, María Lourdes
AU - Sirtl, Simon
AU - Weingarten, Mark
AU - Sandru, Vasile
AU - Woitalla, Julia
AU - Ellenrieder, Volker
AU - Neesse, Albrecht
N1 - Publisher Copyright:
© 2023 BMJ Publishing Group. All rights reserved.
PY - 2023/12/21
Y1 - 2023/12/21
N2 - Objective Early disease prediction is challenging in acute pancreatitis (AP). Here, we prospectively investigate whether the microbiome predicts severity of AP (Pancreatitis—Microbiome As Predictor of Severity; P-MAPS) early at hospital admission. Design Buccal and rectal microbial swabs were collected from 424 patients with AP within 72 hours of hospital admission in 15 European centres. All samples were sequenced by full-length 16S rRNA and metagenomic sequencing using Oxford Nanopore Technologies. Primary endpoint was the association of the orointestinal microbiome with the revised Atlanta classification (RAC). Secondary endpoints were mortality, length of hospital stay and severity (organ failure >48 hours and/or occurrence of pancreatic collections requiring intervention) as post hoc analysis. Multivariate analysis was conducted from normalised microbial and corresponding clinical data to build classifiers for predicting severity. For functional profiling, gene set enrichment analysis (GSEA) was performed and normalised enrichment scores calculated. Results After data processing, 411 buccal and 391 rectal samples were analysed. The intestinal microbiome significantly differed for the RAC (Bray-Curtis, p value=0.009), mortality (Bray-Curtis, p value 0.006), length of hospital stay (Bray-Curtis, p=0.009) and severity (Bray-Curtis, p value=0.008). A classifier for severity with 16 different species and systemic inflammatory response syndrome achieved an area under the receiving operating characteristic (AUROC) of 85%, a positive predictive value of 67% and a negative predictive value of 94% outperforming established severity scores. GSEA revealed functional pathway units suggesting elevated short-chain fatty acid (SCFA) production in severe AP. Conclusions The orointestinal microbiome predicts clinical hallmark features of AP, and SCFAs may be used for future diagnostic and therapeutic concepts. Trial registration number NCT04777812.
AB - Objective Early disease prediction is challenging in acute pancreatitis (AP). Here, we prospectively investigate whether the microbiome predicts severity of AP (Pancreatitis—Microbiome As Predictor of Severity; P-MAPS) early at hospital admission. Design Buccal and rectal microbial swabs were collected from 424 patients with AP within 72 hours of hospital admission in 15 European centres. All samples were sequenced by full-length 16S rRNA and metagenomic sequencing using Oxford Nanopore Technologies. Primary endpoint was the association of the orointestinal microbiome with the revised Atlanta classification (RAC). Secondary endpoints were mortality, length of hospital stay and severity (organ failure >48 hours and/or occurrence of pancreatic collections requiring intervention) as post hoc analysis. Multivariate analysis was conducted from normalised microbial and corresponding clinical data to build classifiers for predicting severity. For functional profiling, gene set enrichment analysis (GSEA) was performed and normalised enrichment scores calculated. Results After data processing, 411 buccal and 391 rectal samples were analysed. The intestinal microbiome significantly differed for the RAC (Bray-Curtis, p value=0.009), mortality (Bray-Curtis, p value 0.006), length of hospital stay (Bray-Curtis, p=0.009) and severity (Bray-Curtis, p value=0.008). A classifier for severity with 16 different species and systemic inflammatory response syndrome achieved an area under the receiving operating characteristic (AUROC) of 85%, a positive predictive value of 67% and a negative predictive value of 94% outperforming established severity scores. GSEA revealed functional pathway units suggesting elevated short-chain fatty acid (SCFA) production in severe AP. Conclusions The orointestinal microbiome predicts clinical hallmark features of AP, and SCFAs may be used for future diagnostic and therapeutic concepts. Trial registration number NCT04777812.
UR - https://www.scopus.com/pages/publications/85185788371
U2 - 10.1136/gutjnl-2023-330987
DO - 10.1136/gutjnl-2023-330987
M3 - Article
C2 - 38129103
AN - SCOPUS:85185788371
SN - 0017-5749
VL - 73
SP - 485
EP - 495
JO - Gut
JF - Gut
IS - 3
ER -